New York Academy pulmonary meeting--March 22, 1990

Our plain-English summary of New York Academy pulmonary meeting--March 22, 1990, by W. Kreutner, W. Selig (Agents and Actions, 1991).

The study

• Authors: W. Kreutner, W. Selig
• Journal: Agents and Actions
• Published: 1991;32(3-4):151-3
• Read it: PubMed · Publisher · Free full text

In plain English

This is a meeting report, not an original study. The authors summarized a lung inflammation meeting held March 22, 1990 at the New York Academy of Sciences. Only the first of five talks concerned asbestos; the rest covered adult respiratory distress syndrome and asthma. In it, Dr. Joe G. N. Garcia of Indiana University reviewed asbestos-induced lung inflammation. The talk noted no evidence that neutrophil elastase is involved in asbestosis, though active collagenase I was markedly increased. Earlier work by Garcia and colleagues (1989), cited in the talk, found that, in laboratory tests, alveolar macrophages (lung immune cells) taken from asbestosis patients released more leukotriene B4, a white-blood-cell attractant, both unstimulated and when stimulated. Its levels in the patients' lung-wash fluid also rose significantly after asbestos challenge. Preliminary evidence suggested asbestos may switch on the gene for interleukin-1, an inflammatory signal. Dr. Garcia proposed that asbestos-activated macrophages release attractants such as leukotriene B4, drawing in neutrophils and eosinophils whose collagenase and reactive oxygen species ultimately cause lung injury and scarring (interstitial fibrosis). No fiber types or patient numbers were reported.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: meeting report summarizing talks at a scientific meeting; the asbestos content is a speaker's review talk, not original research by the report's authors
• Who was studied: A meeting on pulmonary inflammation held March 22, 1990 at the New York Academy of Sciences. The asbestos portion was a review talk by Dr. Joe G. N. Garcia (Indiana University School of Medicine, Indianapolis). The talk cited work on asbestosis patients but did not give their number.
• Exposure: asbestos fibres in the lung; no fiber type, product, job or dose is named
• Main results:
  • Reported in the talk: unlike emphysema, there was no evidence for involvement of neutrophil elastase in asbestosis. There was a marked increase in active collagenase I, which may be neutrophil derived.
  • Earlier work by Garcia et al. (Am. Rev. Respir. Dis. 1989), cited in the talk, showed enhanced release of leukotriene B4 by lung-wash (BAL) macrophages isolated from asbestosis patients. The release was measured in vitro, both basal and after stimulation with A23187 or arachidonic acid.
  • In this group of asbestosis patients, significant elevations in BAL fluid leukotriene B4 were noted following asbestos challenge. No figures were given.
  • Preliminary evidence was presented suggesting that asbestos interacts with monocytes/macrophages to induce gene expression of the inflammatory signal interleukin-1.
• The authors' conclusion: The report's authors gave no conclusion of their own on asbestos. The speaker, Dr. Garcia, proposed that asbestos-induced activation of alveolar macrophages releases chemotactic factors such as leukotriene B4, which attract neutrophils and eosinophils. In his proposal, these cells release active collagenase and reactive oxygen species that ultimately cause parenchymal injury and interstitial fibrosis.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Asbestosis.

Related studies

• Omentin-A Novel Adipokine in Respiratory Diseases — Y. Zhou, B. Zhang, et al. (2017)
• Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma — M.T. Siddiqui, F. Schmitt, et al. (2019)
• Biological effects of asbestos: New York Academy of Sciences 1964 — M. Greenberg (2003)
• Single site venovenous extracorporeal membrane oxygenation as an alternative to invasive ventilation in post-pneumonectomy fistula with acute respiratory failure — M. Fica, F. Suárez, et al. (2012)
• An Approach to Overcome the Limitations of Surveillance of Asbestos Related Diseases in Low- and Middle-Income Countries: What We Learned from the Sibaté Study in Colombia — J.P. Ramos-Bonilla, M. Giraldo, et al. (2023)
• An 80-Year-Old Man With Asbestos Exposure Presenting With Respiratory Distress — A. Aron, A.E. Urban, et al. (2017)

Browse return to medical research.